PTO/SB/08a (02-18)
`Approvedfor use through 11/30/2020. OMB 0651-0031
`.
`.
`.
`sg.
`U.S. Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Doc description: Information Disclosure Statement (IDS) Filed
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Number
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`| 7870171
`
`omarSSCS
`
`
`
`
`| P04000USC8
`
` Doc code: IDS
`
`
`Filing Date
`
`First Named Inventor
`
`
`
`
`Art Unit
`
`
`
`U.S.PATENTS [Remove|
`
`
`Examiner] Cite
`Initial*
`No
`
`Patent Number
`
`Kind
`Code’ Issue Date
`
`Name of Patentee or Applicant
`of cited Document
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`
`
`
`
`
`
`ILTON S. ISAACSON
`
`
`
`
`
`DAVID C. MAC GREGOR
`
`
`
`RUDOLF R. SCHULTE
`
`EFS Web 2.1.18
`
`

`

`17870171
`Application Number
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Ant Uninit
`
`2022-07-21
`Filing Date
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`eoCo~~~~~~~~ooaoaoooon==oOonNOoa©coonNOcoa~©WwCc=oOoOaoon©=onoSNOw_mo©~l~lcoonCooNO=NoaCo==KONoaoa=©=~~NoaoNoNo
`
`| PO4000USC8
`
`986-05-20
`
`lausen etal.
`
`986-12-02
`
`987-04-07
`
`orbett
`
`987-08-18
`
`987-09-29
`
`987-11-03
`
`988-03-01
`
`—_h
`
`988-06-28
`
`enseyetal.
`
`988-09-06
`
`LJ
`
`oao]o=o=syown
`
`989-04-04
`
`989-07-11
`
`ampleretal.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`©©©©o©©©©©coaaaa&=SoSooSoo&~a&©ooONSoafer)coon&~ooNoNSNSaaaonnnN&=NS~NSna&&aNsANoi)~sl
`
` | PO4000USC8 _2=| c3 |@n o= Q
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`990-01-23
`
`joise et al.
`
`990-02-13
`
`rouplin
`
`990-02-20
`
`ilder et al.
`
`990-03-06
`
`990-03-13
`
`joise et al.
`
`990-04-24
`
`Na
`
`990-07-31
`
`arriker et al.
`
`990-09-11
`
`990-09-18
`
`hardack
`
`990-10-23
`
`990-11-13
`
`wang et al.
`
`EFS Web 2.1.18
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
` Attorney Docket Number
`
`
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`990-12-11
`
`991-01-15
`
`991-02-19
`
`oZU
`
`991-02-26
`
`991-03-19
`
`offmann etal.
`
`
`CJCJCJCJCJCJCJaSSaaSSoSoSSoSSowowowowowocoaoaoeaoeBooawowoc=]NOwo=kwoon—_aoonaoeonOocoSoNo—_SoSo—_coSoSoNO&=aaw=a=~lan==—oyoOoONOeo~]~]~]oySo
`
`| P04000USC8
`
`Wwao
`
`991-06-04
`
`991-09-03
`
`991-09-17
`
`991-10-29
`
`992-02-18
`
`992-03-03
`
`EFS Web 2.1.18
`
`gS.5=>5oFT
`
`astillo et al.
`
`olding et al.
`
`illner et al.
`
`oOQ o
`
`

`

`
`
`
`
`Application Number 17870171
`
`Examiner Name Attorney Docket Number
`
`
`
`
`OGOGOGOGOGOGOGOGOGOGOGBo—_—_—_—_—_—_—_—_—_QoaooO~ooOo.No==oS©=ao=cowe~~©NoNooFcoOoonNoow©=lo]wnNwNo=NO=~~=lee)lee)ioSo>aooCoNocoQooOw©aocooO
`LWUfLWLUUfej@55z&=a=3Rrsi3NwiaQoo
`
`| P04000USC8
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`( Not for submission under 37 CFR 1.99)
`
`992-03-24
`
`992-04-21
`
`Idall et al.
`
`992-05-12
`
`Saacsonetal.
`
`992-05-12
`
`992-07-14
`
`992-09-15
`
`992-11-17
`
`bh~]
`
`992-12-08
`
`iguera
`
`992-12-15
`
`993-03-02
`
`ongeretal.
`
`993-04-13
`
`elte Jr. et al.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`Examiner Name Attorney Docket Number
`
`
`
`CJCJCJCJCJCJCJCJCJCJCJwewwwwwewNoNoNoNONo~lor>>=oSwowwLe)=ley)oaooaMNSoSoai—_=—=oowe=NQ-=Noon==on===NO=oS~=>~eow=No~ao~oSa
`
`| P04000USC8
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`( Not for submission under 37 CFR 1.99)
`
`993-05-18
`
`Saacsonetal.
`
`993-06-22
`
`Parker
`
`993-08-10
`
`eirstein et al.
`
`993-08-10
`
`acaulay et al.
`
`aco
`
`994-03-01
`
`994-04-05
`
`994-05-17
`
`uri
`
`994-09-06
`
`994-09-13
`
`ESU a3iY) @a a
`
`62
`
`994-11-01
`
`lausen etal.
`
`994-12-27
`
`arvik
`
`EFS Web 2.1.18
`
`

`

`
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`Ant Uninit
`
`Examiner Name
`
` Attorney Docket Number
`
`
`
`| PO4000USC8 eope ozeman Jr. et al.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`repe
`eeee
`
`ementetal.
`
`aheret al.
`
`artin
`
`ee
`
`hosravi
`
`irose et al.
`
`ubbardetal.
`
`Abramsetal.
`
`Anaya Fernandez de Lomana
`
`EFS Web 2.1.18
`
`

`

`
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
` Attorney Docket Number
`
`
`
`| PO4000USC8
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`First Named Inventor Mark WV. McBride
`Ant Uninit
`
`Examiner Name
`
`allace etal.
`
`ayloret al.
`
`aplanetal.
`
`arvik
`
`osgrove et al.
`
`ozeman Jr. et al.
`
`ozeman Jr. et al.
`
`aheret al.
`
`arson Jr. et al.
`
`EFS Web 2.1.18
`
`

`

`
`
`| PO4000USC8
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Ant Uninit
`
`2022-07-21
`Filing Date
`
`™
`_—
`
`| |
`
`|
`
`"
`
`|
`
`_
`
`EFS Web 2.1.18
`
`
`
`17870171
`Application Number
`
`Examiner Name Attorney Docket Number
`
`
`

`

`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`Ant Uninit
`
` Attorney Docket Number
`
`
`CJCJCJCJCJCJCJCJCJCJCJowooeoeoecocococooe~BO=coooanonNO=So~~==cococote)=osa~woie}o>No~~om=oSoSies)~!=co4oSoco~~~==NOwonNowNoNo>oS===
`
`| PO4000USC8
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`oO~]
`
`998-07-14
`
`998-09-15
`
`Palestrant
`
`998-09-29
`
`orace
`
`998-10-20
`
`arvik
`
`998-12-22
`
`arvik et al.
`
`102
`
`999-01-12
`
`rowell etal.
`
`103
`
`999-02-09
`
`Stevenset al.
`
`104
`
`999-02-09
`
`ertolero et all.
`
`105
`
`999-03-30
`
`Antaki et al.
`
`999-06-15
`
`eee
`me
`
`107
`
`999-07-13
`
`EFS Web 2.1.18
`
`

`

`
`
`17870171
`Application Number
`
`Examiner Name Attorney Docket Number
`
`
`
`O)O)O)O)O)O)O)CJCJCJCJSoSoSoSoSooSoSwowowo©nnon===SoSooononalor)wwcoonon~~~~=~~—_==~"~nNaoNoaaoo(SnNco=oSoSw~l~~~te}=oO=wooneo>NOwoeo>=ww
`
`| PO4000USC8
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Ant Uninit
`
`2022-07-21
`Filing Date
`
`999-08-24
`
`Sievers et al.
`
`999-09-14
`
`ayloret al.
`
`999-09-28
`
`999-10-12
`
`999-12-28
`
`999-12-28
`
`pe
`eee
`eee
`
`
`= = Bo
`
`113
`
`114
`
`POO0-01-18
`
`Antakietal.
`
`115
`
`™
`
`POO0-01-18
`
`POO0-01-25
`
`aheretal.
`
`117
`
`PO00-04-
`
`Noan
`
`Schobetal.
`
`PO00-05-02
`
`ickley
`
`EFS Web 2.1.18
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
`|POO0-07-11
`
`
`Aboul-Hosnetal.
`
`125
`
`127
`
`EFS Web 2.1.18
`
`|PO00-09-05
`
`
`Aboul-Hosnetal.
`
`

`

`
`
`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`( Not for submission under 37 CFR 1.99)
`
` 134
`|POOO-11-28
`Aboul-Hosnetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`( Not for submission under 37 CFR 1.99)
`
`142
`
`144
`
`148
`149
`
`|P001-04-03
`
`
`Aboul-Hosnetal.
`
`|P001-04-03
`
`
`Aboul-Hosnetal.
`
`|P001-05-08
`|P001-05-22
`
`Aboul-Hosn
`
`Aboul-Hosnetal.
`
`151 pr|P001-06-12 zetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
`Examiner Name Attorney Docket Number
`|
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`P001-06-12
`
`ampbell et al.
`
`
`
`| P04000USC8 Bolling etal.
`
`P001-06-19
`
`azatchkovetal.
`
`
`|~-, pee
`|~- me
`
`| ~-
`
`P001-09-11
`
`
`
`Aboul-Hosnetal.
`
`| ~- |
`
`P001-10-02
`
`
`
`Aboul-Hosnetal.
`
`| ~ / ~
`
`| ~ / —
`
`P002-05-14
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
`Examiner Name Attorney Docket Number
`|
`
`
`COCOCOCOCOCOCOCOCOCOCOaaabBaaazBOooOoOoatnRhNONONO=oooooOooo=~ooaNDOoa~~NN~SaooSNoa~No~&aorte)NyNn~~=coa=b=oNoO
`
`| P04000USC8
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`PO02-05-28
`
`
`
`Aboul-Hosnetal.
`
`|—
`
`| pe
`
`| |
`
`— pe
`|- pee
`
`
`Demarais et al.
`
`PO02-09-24
`
`|- ~
`
`|~ -
`
`|~ "
`
`163
`
`164
`
`165
`
`167
`
`170
`
`171
`
`172
`
`173
`
`P003-01-21
`
`rbel et al.
`
`EFS Web 2.1.18
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
` 177
`
`|P003-03-18
`|P003-03-18
`
`Aboul-Hosnetal.
`Schmitz-Rodeetal.
`
`178
`
`184
`
`EFS Web 2.1.18
`
`|P003-09-02
`
`Aboul-Hosnetal.
`
`

`

`
`
`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`|PO03-11-04
`
`Aboul-Hosnetal.
`
` |
`Aboul-Hosnetal.
`
`192
`
`195
`
`EFS Web 2.1.18
`
`|PO03-12-09
`
`Demaraisetal.
`
`|P004-03-23
`
`

`

`
`
`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`( Not for submission under 37 CFR 1.99)
`
` 203
`|PO04-11-09
`Aboul-Hosnetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`Ant Uninit
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`207
`
`|P005-03-15
`
`jongetal.
`
`209
`210
`211
`
`|P005-05-03
`|P005-08-09
`|P005-08-30
`
`
`
`Bollingetal.
`Aboul-Hosnetal.
`Aboul-Hosnetal.
`
`
`
`
`
`216 br|PO05-12-13
`217
`|PO06-01-03
`
`
`Aboul-Hosnetal.
`hawetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
` Attorney Docket Number
`
`
`
`| PO4000USC8 olling et al.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`First Named Inventor Mark WV. McBride
`Ant Uninit
`
`Examiner Name
`
`Bechert et al.
`
`Aboul-Hosnetal.
`pe
`
`a i
`
`ole etal.
`
`EFS Web 2.1.18
`
`

`

`
`
`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`( Not for submission under 37 CFR 1.99)
`
` 234
`|POO7-07-10
`Ainsworthetal.
`
`EFS Web 2.1.18
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
`|P008-06-03
`
`
`Aboul-Hosnetal.
`
`|P009-12-15
`
`
`asoudipouretal.
`
`|P008-12-30
`
`ray
`
`242
`
`244
`
`249
`
`EFS Web 2.1.18
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
`|P010-05-25
`|P010-06-08
`
`enkeretal.
`
`Aboul-Hosnetal.
`
`251
`252
`
`257
`258
`
`260
`
`EFS Web 2.1.18
`
`|P010-08-31
`|P010-10-26
`
`
`
`Aboul-Hosnetal.
`Ainsworthetal.
`
`|P010-11-30
`
`cBrideetal.
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
`|DO11-05-17
`
`haw
`
`263
`
`EFS Web 2.1.18
`
`

`

`Application Number 17870171
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name Attorney Docket Number
`
`
`
`
`
`
`| P04000USC8
`
`278
`279
`
`|P012-10-02
`|P012-11-27
`
`
`
`Demaraisetal.
`Bellevilleetal.
`
`281 be|P013-01-29
`
`
`Piancaetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`Examiner Name Attorney Docket Number
`
`
`
`
`| P04000USC8
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`
`Art Unit |
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`290
`
`|P014-08-26
`
`astieetal.
`
`292 be|P014-11-18
`
`Aboul-Hosnetal.
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`Filing Date 2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT | .
`
`( Not for submission under 37 CFR 1.99)
`
`Art Unit
`
`
`
`| P04000USC8
`
`Attorney Docket Number
`
`9089670 |
`9217442 |
`
`Scheckel
`iessleretal.
`
`295
`296
`
`298
`299
`
`0328741 |P016-05-03
`9358330 |
`
`
`i
`Schumacher
`
`If you wish to add additional U.S. Patent citation information please click the Add button.
`
`Add
`
`
`
`Examiner Name
`
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Pages,Columns,Lines where
`
`
` Kind|PublicationExaminer Publication
`
`Name of Patentee or Applicant
`of cited Document
`Cite No
`Relevant Passages or Relevant
`
`Initial*
`Number
`Code’! Date
`Figures Appear
`
`
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`
`
`
` If you wish to add additional U.S. Published Application citation information please click the Add button!
`Name of Patentee or
`
`Pages,Columns,Lines
` Kind|PublicationExaminer where Relevant
`
`
`Country
`Cite|Foreign Document
`Code2j
`Applicant of cited
`Initial*
`Numbers
`Code?4) Date
`Passages or Relevant
`Document
`Figures Appear
`
`EFS Web 2.1.18
`
`

`

`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`===-.=NONONow~wo©oo©~loe>=oaoawoNooodoodoo>anoO>OoQo
`
` | PO4000USC8
`
`=
`
`2009-04-16
`
`9613565
`
`LJ
`
`m
`
`—_
`
`1997-07-24
`
`1990-04-18
`
`au Guenter Prof Dr
`
`N533432
`
`207934
`
`591079
`
`P151257
`
`1993-03-24
`
`2002-05-29
`
`2005-11-02
`
`2010-02-10
`
`=
`
`=
`
`1
`
`=
`
`P263732
`
`2010-12-22
`
`2011-03-23
`
`1975-11-14
`
`1991-07-10
`
`EFS Web 2.1.18
`
`-MED SYSTEMS, INC
`
`ordis Corp
`
`DELGADO, REYNOLDS
`
`
`
`nnovative Solutions
`
`AN FAI * SHIU
`
`
`
`
`
`

`

`
`
`17870171
`Application Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`=,=,=,oSSoSoSoSoSo===oSoSw©NocoNOoaao==~onaoofy~!aNo~laoa = SDea
`====~o
`
` | PO4000USC8
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`—_ No
`
`2002-02-19
`
`w
`
`P011157961
`
`2011-08-18
`
`06114101
`
`1994-04-26
`
`—_
`
`08196624
`
`1996-08-06
`
`1998-04-21
`
`1973-03-16
`
`1983-11-07
`
`2002-08-01
`
`1099447
`
`54823295
`
`558190448
`
`=
`
`=
`
`hoNoSo
`
`NoNo
`
`EFS Web 2.1.18
`
`2000-03-09
`
`2000-04-06
`
`2000-07-27
`
`
`
`
`
`BOSTON SCIENT LTD
`
`PENN STATE
`
`IPPON ZEON CO LTD
`
`INNESOTA MINING
`and MFG CO 3M
`
`ITINOL DEVICES and
`OMPONENTSING
`
`o Applicant
`
`AARU AIGUNAA
`
`ND TECH RES INST
`
`-MED SYSTEMS ING
`
`
`
`A. Med Systems Inc
`
`ardeon Corp
`
`

`

`
`
`
`Application Number
`17870171
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE
`
`First Named Inventor|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`
`
`Art Unit |
`
` Attorney Docket Number
`
`
`| PO4000USC8
`
`
`mpella Cardiosystems
`
`Examiner Name
`
`Now
`
`Boag
`
`=©oo&aco~©
`
`=
`
`=
`
`2000-11-23
`
`A. Med Systems Inc
`
`2001-04-12
`
`Nooa
`
`)2070039
`
`2002-09-12
`
`hree Arch Partners
`
`=3S©oo~o
`
`ww
`
`N3048582
`
`=
`
`2003-06-12
`
`(ORN GMBH and CO.
`G
`
`N3103745
`
`2003-12-18
`
`Aboul-hosn Walid
`
`P005089674
`
`2005-08-29
`
`edtronic VascularInc
`
`P005123158
`
`P006051023
`
`P009073037
`
`=
`
`=
`
`1
`
`2005-12-29
`
`Orgis Medical Corp
`
`2006-05-18
`
`2009-06-11
`
`wNo
`
`P009076460
`
`2009-06-18
`
`ornova Inc
`
`ww
`
`P010133567
`
`=
`
`2010-11-25
`
`EFS Web 2.1.18
`
`

`

`
`
`17870171
`Application Number
`
` Attorney Docket Number
`
`2022-07-21
`Filing Date
`
`First Named Inventor Mark WV. McBride
`
`Art Unit
`
`Examiner Name
`
`=
`
`=
`
`=
`
`=
`
`=
`
`=
`
`1
`
`=
`
`2010-12-29
`
`cp Entwicklungsges
`
`2011-03-31
`
`2011-03-31
`
`2011-04-07
`
`Abiomed Europe Gmbh
`
`2011-06-30
`
`cp Entwicklungsges
`
`2011-07-28
`
`2012-01-19
`
`2012-01-19
`
`2013-10-31
`
`Abiomed Europe Gmbh
`
`2014-02-06
`
`Shanghai Childrens
`edical Ct Affiliated To
`
`
`
`
`| PO4000USC8
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`P010149393
`
`P01 1035926
`
`P011035929
`
`P011039091
`
`P011076439
`
`P011089022
`
`P012007140
`
`P012007141
`
`P013160407
`
`P014019274
`
`Wwng
`
`wwa
`
`wao
`
`>awwwwoS©co~
`
`=
`
`feBo
`
`aw
`
`ihBK
`
`EFS Web 2.1.18
`
`P015063277
`
`2015-05-07
`
`cp Entwicklungsges
`
`

`

`
`Application Number
`17870171
`
`Filing Date
`2022-07-21
`
` INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
` Attorney Docket Number
`
`( Not for submission under 37 CFR 1.99)
`
`
`Examiner Name
`
`| P04000USC8
`
`
`
`
`
`
`
`
` NON-PATENT LITERATURE DOCUMENTS
`
`
`1994-03-17
`
`Reitan Oeyvind
`
`1995-10-12
`
`Prograft Medical Inc
`
`1997-05-01
`
`aosems Technology
`
`1999-07-29
`
`EDTRONIC, INC
`
`1999-09-10
`
`uenther Rolf W
`
`1999-11-25
`
`-MED SYSTEMS, INC
`
`Remove
`
`‘Statistical Analysis and Clinical Experience with the Recover® Pump Systems", Impella CardioSystems GmbH, 2?
`sheets.
`
`ABIOMED- Recovering hearts. Savinglives., Impella 2.5 System, Instructions for Use, July 2007, 86 sheets.
`
`ABIOMED, "Impella 5.0 with the Impella Console, Circulatory Support System, Instructions for Use Clinical Reference
`anual,” June 2010, 122 pages.
`
`
`
`
`
`EFS Web 2.1.18
`
`. .,_|Include nameof the author (in CAPITAL LETTERS),title of the article (when appropriate),title of the item
`
`Examiner] Cite
`_
`:
`:
`.
`Initials*
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`Ts
`publisher, city and/or country where published.
`
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`Art Unit
`|
`
`
`
` Attorney Docket Number
`
`
`
`
`| P04000USC8 atheter as a Pulsatile Left Ventricle-Femoral Artery Bypass, Artificial Organs, 16 (3): 286-90, 1992.
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`BARRASet al., "Nitinol-lts Use in vascular Surgery and Other Applications,” Eur J. Vasc Endovasc Surg, 2000, pp.
`564-569, Vol. 19
`
`BISCARINI et al., "Enhanced nitinol properties for biomedical applications," Recent Patents on Biomedical
`ngineering, 2008, pp. 180-196, Vol. 1(3)
`
`ardiovascular Diseases (CVDs) Fact Sheet No. 317. World Health Organization. [Online] September 2011. http://
`.who.intfmediacentre/factsheets/fs31 //en/index html, accessed on 8/29/2012
`
`DUERIG et al., "An Overview of Nitinol Medical Applications," Mat Sci Eng, 1999, pp. 149-160
`
`uropean Search Report received from the European Patent Office in EP Application No. EP 05799883.3 dated May
`0, 2011, 4 pages.
`
`xtended European Search Report dated October 8, 2012, received in EP Appl. No. 07753903.9, in 7 pages
`
`ederal and Drug Administration 510(k) Summary for Predicate Device IMPELLA 2.5 (K112892)}, prepared on
`September 5, 2012
`
`RECH, "Percutaneous coronary intervention. |: History and development,” BMJ., 2003, pp.1080-1082, Vol. 326
`
`SU et al., "Review of Recent Patents on Foldable Ventricular Assist Devices,” Recent Patents on Biomedical
`ngineering, 2012, pp. 208-222, Vol. 5
`
`DE, Hirofumi et al., Evaluation of the Pulsatility of a New Pulsatile Left Ventricular Assist Device--the Integrated
`ardioassist Catheter—in Dogs, J. of Thoracic and Cardiovascular Surgery 107 (2): 569-75; Feb. 1994.
`
`DE, Hirofumi et al., Hemodynamic Evaluation of a New Left Ventricular Assist Device: An Integrated Cardioassist
`
`wNo
`
`—_h
`
`EFS Web 2.1.18
`
`

`

`
`Filing Date
`2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`Art Unit
`|
`
`
`
`( Not for submission under 37 CFR 1.99)
`
` Attorney Docket Number
`
`
`
`
`
`Application Number 17870171
`
`| P04000USC8
`
`
`
`
`Examiner Name
`
`nternational Search Report received in International Patent Application No. PCT/US2003/04401, mailed on November
`0, 2003,filed on February 13, 2003, 9 pages
`
`nternational Preliminary Examination Report from the European Patent Office received in PCT Application No. PCT/
`$2003/04401, mailed May 19, 2004, 4 pages.
`
`nternational Preliminary Examination Report from the European Patent Office received in PCT Application No. PCT/
`$2003/04853, mailed July 26, 2004, 5 pages.
`
`nternational Preliminary Report on Patentability and Written Opinion of the International Searching Authority received
`mn PCT Application No. PCT/US2005/033416, mailed March 20, 2007, / pages.
`
`nternational Preliminary Report on Patentability and Written Opinion of the International Searching Authority received
`mn PCT Application No. PCT/US2007/007313, mailed September 23, 2008, 6 pages.
`
`nternational Search Report and Written Opinion receivedin International Patent Application No. PCT/US2013/040798,
`ailed August 21, 2013, in 16 pages.
`
`nternational Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040809,
`ailed September 2, 2013, in 25 pages.
`
`nternational Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048332,
`ailed October 16, 2013, in 1/ pages.
`
`nternational Search Report and Written Opinion receivedin International Patent Application No. PCT/US2013/048343,
`ailed October 11, 2013, in 15 pages.
`
`nternational Search Report and Written Opinion receivedin International Patent Application No. PCT/US2014/020878,
`ailed May 7, 2014, in 13 pages
`
`nternational Search Report and Written Opinion received in International Patent Application No.PCT/US2013/040799,
`ailed August 21, 2013, in 19 pages.
`
`= ol
`
`~!
`
`NohoNo=No=So
`
`Now
`
`Boag
`
`Nooa
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
`
`
`Art Unit |
`
` Attorney Docket Number
`
`
`
`
`| P04000USC8 Organs 21(5) 425-27, 1997.
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`nternational Search Report and Written Opinion received in PCT Application No. PCT/US2012/020369 mailed July 30,
`
`nternational Search Report and Written Opinion received in PCT Application No. PCT/US2012/020382, mailed July
`
`nternational Search Report and Written Opinion received in PCT Application No. PCT/US2012/020383 mailed August
`
`nternational Search Report received in PCT Application No. PCT/US2005/033416, mailed December 11, 2006, 4
`
`ntemational Search Report received in PCT Application No. PCT/US2007/07313, mailed March 4, 2008, 3 pages.
`
`nterational Search Report Written Opinion received in PCT Application No. PCT/US2010/040847 mailed on
`December 14, 2010
`
`nternational Search Report received in International Patent Application No. PCT/US2003/04853, mailed July 3, 2003,
`
`RISHNAMANT et al., "Emerging Ventricular Assist Devices for Long-Term Cardiac Support," National Review,
`ardiology, February 2010, pp. 71-76, Vol. 7
`
`IHAYLOV, D. et al., Evaluation of the Optimal Driving Mode During Left Ventricular Assist with Pulsatile Catheter
`Pump in Calves, Artificial Organs 23(12). 1117-22, 1999
`
`IHAYLOV,Dimiter et al., Development of a New Introduction Technique for the Pulsatile Catheter Pump,Artificial
`
`Noao
`
`No~!
`
`Noco
`
`wwwwwNowNo=Sowo
`
`wwwa
`
`wao
`
`EFS Web 2.1.18
`
`

`

`
`
`
`
`Application Number 17870171
`
`
`
`Filing Date 2022-07-21
`
`
`
`Art Unit |
`
` Attorney Docket Number
`
`
`
`
`| P04000USC8 he Acutely Failing Heart. The Journal of Thoracic and Cardiovascular Surgery, Nov. 1992, Vol. 118, No. 5, pp.
`
`INFORMATION DISCLOSURE
`First Named Inventer|Mark W. McBride
`STATEMENT BY APPLICANT
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`ORGAN, "Medical Shape memory alloy applications-the market and its products,” Mat Sci Eng, 2004, pp. 16-23, Vol.
`oy ~!co
`
`ORSINK, PLJ et al., Numerical Modelling of Blood Flow Behaviour in the Valved Catheter of the PUCA Pump, a
`VAD, The International Journal of Artificial Organs 20(5): 277-284; 1997.
`
`ISHIMURA et al. The enabler cannula pump: a novel circulatory support system. The International Journalof Artificial
`Organs, Vol. 22, No. 5, 1999, pp. 317-323
`
`PETRINI et al., "Biomedical Applications of Shape Memory Alloys," Journal of Metallurgy, 2011, pp. 1-15
`
`RAESSet al., "Impella 2.5," J. Cardiovasc. Trans. Res., 2009, pp. 168-172, Vol. 2(2)
`
`AKHORST, Gerhard etal., In Vitro Evaluation of the Influence of Pulsatile Intraventricular Pumping on Ventricular
`Pressure Pattems, Artificial Organs 18(7): 494-99; 1994.
`
`REITANet al., "Hemodynamic Effects of a New Percutaneous Circulatory Support Device in a Left Ventricular Failure
`jodel,”" ASAIO Joumal, 2003, pp. 731-736, Vol. 49
`
`REITAN, Oyvind, et al., Hydrodynamic Properties of a New PercutaneousIntra-aortic Axial Flow Pump. ASAIO Journal
`POOO. pp. 323-328.
`
`Schmitz-Rode, Thomaset al., "An Expandable Percutaneous Catheter Pump for Left Ventricular Support", Journal of
`he American College of Cardiology, Vo. 45, No. 11, 2005, pp. 1856-1861.
`
`SHABARIetal., "Improved Hemodynamics with a Novel Miniaturized Intra-Aortic Axial Flow Pump in a Porcine Model
`bf Acute Left Ventricular Dysfunction,” ASAIO Joumal, 2013, Vol 59, pp 240-245.
`
`SHARONYet al. Cardiopulmonary Support and Physiology- The Intra-Aortic Cannula Pump: A Novel Assist Device for
`
`wwco~
`
`ww©
`
`>>>>>awoNo=oS
`
`a>aoan
`
`~~]
`
`EFS Web 2.1.18
`
`

`

`
`
`Application Number 17870171
`
`
`Filing Date 2022-07-21
`
`INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
`
`
`
`
`
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`| P04000USC8
`
`SHARONY,R. et al. Right heart support during off-pump coronary artery surgery-a multicenter study. Heart Surg
`orum. 2002,5(1):13-6.
`
`SMITH et al., "First-ln-Man Study of the Reitan Catheter Pump for circulatory Support in Patients Undergoing High-
`isk Percutaneous Coronary Intervention,” Catheter Cardiovasc Interv, 2009, pp. 859-865, Vol. 73(7)
`
`SOKOLOWSKIet al., "Medical Applications of Shape Memory Polymers,” Biomed Mater, 2007, pp. $23-S27, Vol. 73
`
`If you wish to add additional non-patentliterature documentcitation information please click the Add button
`
`EXAMINER SIGNATURE
`
`*EXAMINER:Initial if reference considered, whetheror not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP $01.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). > For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial numberof the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. * Applicantis to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.18
`
`

`

`
`Application Number
`17870171
`
`Filing Date
`2022-07-21
`
` INFORMATION DISCLOSURE First Named Inventor|Mark W. McBride
`
`STATEMENT BY APPLICANT
`|...
`
` Attorney Docket Number
`
`
`Examiner Name
`
`| P04000USC8
`
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection{s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three monthsprior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`[-]
`
`> See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`A certification statement is not submitted herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Signature
`
` Name/Print
`
`2022-07-27
`
`1,785
`
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public whichis to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.18
`
`

`

`Privacy Act Statement
`
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Departmentof Justice to determine whether the Freedom ofInformation Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence toa
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`requestinvolving an individual, to whom the record pertains, when the individual has requested assistance from the
`Memberwith respect to the subject matter of the record.
`
`
`
` The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this sys